维普中文期刊产品整合服务
16篇 您的检索式:作者名="GG Liversidge"
    题名 作者 年代 出处 被引量
1Drug nanoparticles: formulating poorly water-soluble compounds 显示文摘Merisko-Liversidge EM Liversidge GG 2008Toxicol Pathol2008,36,1:1
2Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats 显示文摘Liversidge GG Conzentino P 1995Int J Pharm1995,,125:1
3Nansizing:a formulation approach for poorly-water-soluble compounds显示文摘Liversidge EM Liversidge GG Cooper ER 2003Eur J Pharm Biopharm2003,18,2:1
4Drug nanoparticles:formulating poorly water-soluble compounds显示文摘Merisko-Liversidge EM Liversidge GG 2008Toxicol Pathol2008,36,1:1
5Drug nanoparticles: formulating poorly water-soluble compounds 显示文摘Merisko-Liversidge EM Liversidge GG 2008Toxicol Pathol2008,36,1:1
6Nanosizing: a formulation approach for poorly-water-soluble compounds 显示文摘Merisko-Liversidge E Liversidge GG Cooper ER 2003Eur J Pharm Sci2003,18,2:1
7Nanosizing: a formulation approach for poorly-water-soluble compounds 显示文摘Merisko-Liversidge E Liversidge GG Cooper ER 2003Eur J Pharm Sci2003,18,2:1
8Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats显示文摘Liversidge GG Conzentino P 1995Int J Pharm1995,125,2:1
9Nanosizing:a formulation approach for poorly-water-soluble compounds显示文摘Merisko-Liversidge M Liversidge GG Cooper ER 2003Eur J Pharm Sci2003,18,2:1
10Nanosizing: a formu- lation approach for poorly-water-soluble compounds 显示文摘Liversidge EM Liversidge GG Cooper ER 2003Eur J Pharm Biopharm2003,18,2:1
11Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats显示文摘Liversidge GG Conzentino P 1995lnt J Pharm1995,125,2:1
12Particle size reduction for improvement of oral bioavailability of hydrophobic drugs:Ⅰ.Absolute oral bioavailability of nanocrystalline danazol in beagle dogs显示文摘Liversidge GG Cundy KC 0,,:1
13Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats显示文摘GG Liversidge P Conzentino 1995Int J Pharm1995,125,2:1
14Nanosizing for oral and parenteral drug delivery:a perspective on formulating poorly-water soluble compounds using wet media milling technology显示文摘Merisko-Liversidge E Liversidge GG 2011Adv Drug Deliv Rev2011,63,6:1
15Nanosizing for oral and parenteral drug delivery: A perspective on formulating 显示文摘MERISKO-LIVERSIDGE E LIVERSIDGE GG 2011AdvDrugDelivRev2011,63,6:1
16Drug nanoparticles:formulating poorly water-soluble compounds显示文摘Merisko-Liversidge EM Liversidge GG 2008Toxicol Pathol2008,36,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费